Physician profile
Ryan O'Dell
NPI 1588027247
$11,828.21
in general payments reported to CMS, 2019-2025
9 companies · $166 in 2025
The $166 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $818 · 2022: $10K · 2023: $26.01 · 2024: $407 · 2025: $166.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $590 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $590.15 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $11,348.15 | 2021-2024 | |
| Ethicon US, LLC | $120.00 | 2022 | |
| Tela Bio, INC. | $99.96 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Medtronic, INC. | $88.02 | 2021-2025 | Signia |
| Tactile Systems Technology INC | $50.63 | 2024 | Entre Plus, Flexitouch Plus |
| Davol INC. | $46.56 | 2023-2025 | Phasix Mesh |
| Pacira Pharmaceuticals Incorporated | $29.57 | 2025 | Exparel |
| Boston Scientific Corporation | $28.85 | 2024 | Spyglass Discover |
| Merck Sharp & Dohme LLC | $16.47 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan O'Dell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.